Business Context and Reporting Period
Company: Collegium Pharmaceutical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 13, 2022
Reporting Period: Single event date (April 13, 2022)
Business Context: The registrant is an emerging growth company incorporated in Virginia, with common stock trading on the NASDAQ Global Select Market under the symbol "COLL".
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely to disclose the posting of a corporate presentation.
Material Changes
No material changes to financial position or operations are reported in this filing. The only reported event is the dissemination of investor materials.
Guidance, Outlook, and Management Commentary
Item 7.01 Other Information: On April 13, 2022, the Company posted a corporate presentation to its website. This presentation may be used by representatives in discussions with investors, analysts, or other parties.
Status: The presentation is attached as Exhibit 99.1 and is being furnished, not filed, under Item 7.01.
Risks and Contingencies: No specific risks or contingencies are detailed in this 8-K text.
Key Facts for Investor Verification
- Verify the content of the corporate presentation attached as Exhibit 99.1 for any forward-looking statements or strategic updates.
- Confirm that the presentation is furnished and not filed, meaning it is not subject to the same liability provisions as filed documents under the Securities Exchange Act of 1934.
- Note that this filing contains no new financial data; investors should refer to the most recent 10-K or 10-Q for financial metrics.